- Home
- Radiotherapy Market

Global Radiotherapy Market Analysis
- Published Date: December, 2022 | Report ID: CLS-1920 | No of pages: 225 | Format:
Global Radiotherapy Executive Summary
The market is primarily being driven by reasons such as the rising incidence of cancer, the increased use of radiotherapy in cancer treatment, and technological developments in radiotherapy equipment. The market for radiation oncology is anticipated to be driven by technological developments that increase treatment safety and efficacy. 4D radiation, which combines 4D imaging with radiotherapy, enables real-time tumour tracking and offers exact data on the tumour's size, shape, area, and volume. This combination enables medical professionals to administer a conformal dose while compensating for organ, tumour, or patient movement.
Market Size and Key Findings
The Global Radiotherapy size is at around US $ xx Bn in 2021 and is projected to reach US $ xx Bn in 2030, exhibiting a CAGR of xx% during the forecast period.
Global Radiotherapy Size (In USD Bn)
(2021-2030F)
Market Dynamics
Market Growth Drivers Analysis
Because of recent technical developments, it is now possible to target tumours with solutions that are simple to use, affordable, and more efficient. Global demand for radiation is driven by rising per capita income and individual discretionary money. An additional aspect fueling growth worldwide is the rise in cancer cases. The improvement in real-time imaging, which minimizes exposure to healthy tissues, contributes to better tumour control and hence fuels Global expansion.
Market Restraints
Even though the radiotherapy market is expanding quickly, a number of problems are limiting its expansion. Due to their size, radiotherapy devices need a lot of room. One of the main obstacles is that some nations lack the necessary infrastructure since they spend so little on healthcare. The development is hampered since most developing nations cannot afford advanced radiation therapy technology. Another aspect impeding its expansion is a lack of awareness.
Competitive Landscape
Key Players
The prominent players operating in this market include IsoRay, Inc. (US), Mevion Medical Systems, Inc. (US), Siemens Healthineers AG (Germany), Elekta (Sweden), IBA (Belgium), ViewRay Technologies, Inc. (US), Hitachi Ltd. (Japan), iCAD, Inc. (US), Panacea Medical Technologies Pvt. Ltd. (India), P-cure Ltd. (Israel), ZEISS Group (Germany) and Accuray Incorporated (US)
TABLE OF CONTENT
1. Report Description of the Global Radiotherapy
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Global Radiotherapy Executive Summary
2.1 Global Radiotherapy – Industry Snapshot & key buying criteria, 2021-2030
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of Global Radiotherapy
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis
4. Global Radiotherapy Segmentation
4.1 By Type
4.1.1 External Beam Radiation Therapy
4.1.1.1 Linear Accelerators
4.1.1.2 Compact Advanced Radiotherapy Systems
4.1.1.2.1 Cyberknife
4.1.1.2.2 Gamma Knife
4.1.1.2.3 Tomotherapy
4.1.1.3 Proton Therapy
4.1.1.3.1 Cyclotron
4.1.1.3.2 Synchrotron
4.1.2 Internal Beam Radiation Therapy
4.1.2.1 Brachytherapy
4.1.2.1.1 Seeds
4.1.2.1.2 Applicators and Afterloaders
4.1.2.1.3 Electronic Brachytherapy
4.1.3 Systemic Radiation Therapy
4.1.4 Others
4.2 By Technology
4.2.1 External Beam Radiotherapy
4.2.1.1 Intensity-Modulated Radiation Therapy (IMRT)
4.2.1.2 Image-Guided Radiation Therapy (IGRT)
4.2.1.3 Stereotactic Radiation Therapy (SRT)
4.2.1.4 3D Conformal Radiation Therapy (3D-CRT)
4.2.1.5 Particle Therapy
4.2.2 Internal Beam Radiotherapy
4.2.2.1 Brachytherapy
4.2.2.2 High-Dose Rate Brachytherapy
4.2.2.3 Low-Dose Rate Brachytherapy
4.2.2.4 Image-Guided Brachytherapy
4.2.2.5 Pulse-Dose Rate Brachytherapy
4.2.3 Systemic Radiation Therapy
4.2.3.1 Intravenous Radiotherapy
4.2.3.2 Oral Radiotherapy
4.3 By Application
4.3.1 Breast Cancer
4.3.2 Cervical Cancer
4.3.3 Colon and rectum Cancers
4.3.4 Stomach Cancer
4.3.5 Lung Cancer
4.3.6 Prostate Cancer
4.3.7 Skin Cancer
4.3.8 Liver Cancer
4.3.9 Other types of cancer
4.4 By End User
4.4.1 Hospitals
4.4.2 Radiotherapy Centers & Ambulatory Surgery Centers
4.4.3 Cancer Research Institutes
5. Global Radiotherapy Share
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.1 Overview
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic Initiatives
7.2 Company 2
7.2.1 Overview
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic Initiatives
7.3 Company 3
7.3.1 Overview
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic Initiatives
7.4 Company 4
7.4.1 Overview
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic Initiative
7.5 Company 5
7.5.1 Overview
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic Initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in Global
8.2 Regulatory Framework in Global
8.3 Pricing & Reimbursement Scenario in Global Radiotherapy
9. Factors Driving Future Growth
9.1 New Trends and Development Global Radiotherapy
9.2 Future Opportunities
10. Strategic Recommendations
Segmentation
Radiotherapy Segmentation
By Type (Revenue, USD Billion):
- External Beam Radiation Therapy
- Linear Accelerators
- Compact Advanced Radiotherapy Systems
- Cyberknife
- Gamma Knife
- Tomotherapy
- Proton Therapy
- Cyclotron
- Synchrotron
- Internal Beam Radiation Therapy
- Brachytherapy
- Seeds
- Applicators and Afterloaders
- Electronic Brachytherapy
- Systemic Radiation Therapy
- Others
By Technology (Revenue, USD Billion):
- External Beam Radiotherapy
- Intensity-Modulated Radiation Therapy (IMRT)
- Image-Guided Radiation Therapy (IGRT)
- Stereotactic Radiation Therapy (SRT)
- 3D Conformal Radiation Therapy (3D-CRT)
- Particle Therapy
- Internal Beam Radiotherapy
- Brachytherapy
- High-Dose Rate Brachytherapy
- Low-Dose Rate Brachytherapy
- Image-Guided Brachytherapy
- Pulse-Dose Rate Brachytherapy
- Systemic Radiation Therapy
- Intravenous Radiotherapy
- Oral Radiotherapy
By Application (Revenue, USD Billion):
- Breast Cancer
- Cervical Cancer
- Colon and rectum Cancers
- Stomach Cancer
- Lung Cancer
- Prostate Cancer
- Skin Cancer
- Liver Cancer
- Other types of cancer
By End User (Revenue, USD Billion):
- Hospitals
- Radiotherapy Centers & Ambulatory Surgery Centers
- Cancer Research Institutes
Methodology
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.